Georg Kettschau

928 total citations
18 papers, 427 citations indexed

About

Georg Kettschau is a scholar working on Organic Chemistry, Molecular Biology and Neurology. According to data from OpenAlex, Georg Kettschau has authored 18 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 5 papers in Molecular Biology and 5 papers in Neurology. Recurrent topics in Georg Kettschau's work include Parkinson's Disease Mechanisms and Treatments (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Mass Spectrometry Techniques and Applications (3 papers). Georg Kettschau is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Mass Spectrometry Techniques and Applications (3 papers). Georg Kettschau collaborates with scholars based in Germany, Sweden and United States. Georg Kettschau's co-authors include Lutz F. Tietze, Lutz‐F. Tietze, Andrea Thiele, Lutz Lehmann, Christer Halldin, Tobias Heinrich, Sangram Nag, Gero Nordmann, Andrea Varrone and Miklós Tóth and has published in prestigious journals such as Journal of Medicinal Chemistry, Chemistry - A European Journal and Tetrahedron Letters.

In The Last Decade

Georg Kettschau

18 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Georg Kettschau Germany 12 199 81 65 58 49 18 427
Martine Dhilly France 13 90 0.5× 170 2.1× 80 1.2× 125 2.2× 31 0.6× 34 426
Hanno Schieferstein Germany 11 78 0.4× 129 1.6× 186 2.9× 61 1.1× 51 1.0× 23 466
Doris Stoermer United States 9 208 1.0× 209 2.6× 80 1.2× 81 1.4× 12 0.2× 11 484
M. Fatôme France 11 196 1.0× 109 1.3× 60 0.9× 35 0.6× 7 0.1× 63 472
Cécile Perrio France 15 245 1.2× 180 2.2× 90 1.4× 100 1.7× 13 0.3× 41 567
Yong‐Woon Jung United States 15 68 0.3× 231 2.9× 154 2.4× 110 1.9× 25 0.5× 27 510
Thibault Gendron United Kingdom 10 122 0.6× 83 1.0× 79 1.2× 34 0.6× 71 1.4× 17 421
Marc B. Skaddan United States 14 218 1.1× 234 2.9× 198 3.0× 93 1.6× 18 0.4× 23 816
Tor Kihlberg Sweden 17 278 1.4× 176 2.2× 329 5.1× 108 1.9× 54 1.1× 34 817
Ida Nymann Petersen Denmark 12 111 0.6× 108 1.3× 108 1.7× 55 0.9× 32 0.7× 21 315

Countries citing papers authored by Georg Kettschau

Since Specialization
Citations

This map shows the geographic impact of Georg Kettschau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georg Kettschau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georg Kettschau more than expected).

Fields of papers citing papers by Georg Kettschau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georg Kettschau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georg Kettschau. The network helps show where Georg Kettschau may publish in the future.

Co-authorship network of co-authors of Georg Kettschau

This figure shows the co-authorship network connecting the top 25 collaborators of Georg Kettschau. A scholar is included among the top collaborators of Georg Kettschau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georg Kettschau. Georg Kettschau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Nag, Sangram, Patrik Fazio, Lutz Lehmann, et al.. (2015). In Vivo and In Vitro Characterization of a Novel MAO-B Inhibitor Radioligand, 18F-Labeled Deuterated Fluorodeprenyl. Journal of Nuclear Medicine. 57(2). 315–320. 42 indexed citations
2.
Nag, Sangram, Lutz Lehmann, Georg Kettschau, et al.. (2013). Development of a novel fluorine-18 labeled deuterated fluororasagiline ([18F]fluororasagiline-D2) radioligand for PET studies of monoamino oxidase B (MAO-B). Bioorganic & Medicinal Chemistry. 21(21). 6634–6641. 40 indexed citations
3.
Lesche, Ralf, Georg Kettschau, Niels Böhnke, et al.. (2013). Preclinical evaluation of BAY 1075553, a novel 18F-labelled inhibitor of prostate-specific membrane antigen for PET imaging of prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 41(1). 89–101. 29 indexed citations
4.
5.
Nag, Sangram, Georg Kettschau, Tobias Heinrich, et al.. (2012). Synthesis and biological evaluation of novel propargyl amines as potential fluorine-18 labeled radioligands for detection of MAO-B activity. Bioorganic & Medicinal Chemistry. 21(1). 186–195. 12 indexed citations
6.
Nag, Sangram, Lutz Lehmann, Georg Kettschau, et al.. (2012). Synthesis and evaluation of [18F]fluororasagiline, a novel positron emission tomography (PET) radioligand for monoamine oxidase B (MAO-B). Bioorganic & Medicinal Chemistry. 20(9). 3065–3071. 21 indexed citations
7.
Graham, Keith, Ralf Lesche, Niels Böhnke, et al.. (2012). Radiofluorinated Derivatives of 2-(Phosphonomethyl)pentanedioic Acid as Inhibitors of Prostate Specific Membrane Antigen (PSMA) for the Imaging of Prostate Cancer. Journal of Medicinal Chemistry. 55(22). 9510–9520. 27 indexed citations
8.
Nag, Sangram, Andrea Varrone, Miklós Tóth, et al.. (2011). In vivo evaluation in cynomolgus monkey brain and metabolism of [18F]fluorodeprenyl: A new MAO‐B pet radioligand. Synapse. 66(4). 323–330. 20 indexed citations
9.
Nag, Sangram, Lutz Lehmann, Tobias Heinrich, et al.. (2011). Synthesis of Three Novel Fluorine-18 Labeled Analogues of l-Deprenyl for Positron Emission Tomography (PET) studies of Monoamine Oxidase B (MAO-B). Journal of Medicinal Chemistry. 54(20). 7023–7029. 20 indexed citations
10.
Eis, Knut, et al.. (2005). Kinase Data Mining: Dealing with the Information (Over‐)Flow. ChemBioChem. 6(3). 567–570. 1 indexed citations
11.
Lange, Udo E. W., Wilfried M. Braje, Willi Amberg, & Georg Kettschau. (2003). Solid-Phase synthesis of endothelin receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13(10). 1721–1724. 6 indexed citations
12.
Tietze, Lutz F., et al.. (2001). Highly Efficient Synthesis of Linear Pyrrole Oligomers by Twofold Heck Reactions. Chemistry - A European Journal. 7(2). 368–373. 68 indexed citations
13.
Tietze, Lutz F., et al.. (2001). Highly Efficient Synthesis of Linear Pyrrole Oligomers by Twofold Heck Reactions. Chemistry - A European Journal. 7(2). 368–373. 1 indexed citations
14.
Amberg, Willi M., Heinz Hillen, Rolf Jansen, et al.. (1999). Discovery and Synthesis of (S)-3-[2-(3,4-Dimethoxyphenyl)ethoxy]-2- (4,6-dimethylpyrimidin-2-yloxy)-3,3-diphenylpropionic Acid (LU 302872), a Novel Orally Active Mixed ETA/ETB Receptor Antagonist. Journal of Medicinal Chemistry. 42(16). 3026–3032. 28 indexed citations
15.
Kettschau, Georg & Gerald Pattenden. (1998). An enantiospecific cobaloxime π-cation initiated carbocyclisation. Tetrahedron Letters. 39(14). 2027–2028. 7 indexed citations
16.
Tietze, Lutz F., et al.. (1998). ChemInform Abstract: Hetero‐Diels—Alder Reactions of 1‐Oxa‐1,3‐butadienes. ChemInform. 29(18). 2 indexed citations
17.
Tietze, Lutz‐F., et al.. (1998). Hetero-Diels-Aider Reactions of 1-0xa-1,3-butadienes. Current Organic Chemistry. 2(1). 19–62. 82 indexed citations
18.
Tietze, Lutz F., et al.. (1996). Synthesis of N-Protected 2-Hydroxymethylpyrroles and Transformation into Acyclic Oligomers. Synthesis. 1996(7). 851–857. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026